Molecular Templates, Inc.: debt financing — Molecular Templates gets $560K bridge loan at 13.5% due April 2025; warns no value for shareholders

Molecular Templates, Inc.

Initial Bridge Loan of $560,000 at 13.5% fixed interest, matures April 21, 2025.
Loan secured by first-priority lien on substantially all assets, including IP.
Amended CVR agreement sets repayment maturity at February 1, 2026.
Company cautions trading is highly speculative, does not expect holders to receive value.
Company does not expect to have resources to continue SEC reporting obligations.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Molecular Templates, Inc. incurred loan of $560,000 with K2 HealthVentures LLC at 13.5% per annum maturing April 21, 2025.

Instrument: loan
Principal: $560,000
Counterparty: K2 HealthVentures LLC
Rate: 13.5% per annum
Maturity: April 21, 2025
Event: incurrence

Exact text from the filing

Lenders, Collateral Trustee, and Administrative Agent. Amount . Pursuant to the Loan and Security Agreement, the Lenders agreed to extend to the Company (i) an initial loan of $560,000 which was drawn on the closing date (the “Initial Bridge Loan”) and (ii) subject to Lenders’ approval in each Lender’s sole and absolute discretion and the terms and conditions of

View on SEC.gov

Browse all debt financings →

Source: SEC EDGAR

accession 0001493152-25-008399

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.